There have been five further Coronavirus-related deaths and 423 new cases, according to figures released by the health authorities today.
4 of these deaths occurred in April, and 1 in February.
With six new cases announced today, Laois now has a 14-day incidence rate of 232.6 making us the county with the third worst rate in the country – despite a fall from yesterday’s figure of 244.4.
Just Offaly (366.9) and Westmeath (268.1) have a higher incidence rate now.
Of the cases notified today:
- 219 are men / 201 are women
- 73% are under 45 years of age
- The median age is 30 years old
- 199 in Dublin, 41 in Kildare, 23 in Meath, 20 in Galway, 18 in Westmeath and the remaining 122 spread across 19 other counties.
As of 8am today, 232 COVID-19 patients are hospitalised, of which 56 are in ICU. 13 additional hospitalisations in the past 24 hours.
As of April 4th 2021, 936,087 doses of COVID-19 vaccine have been administered in Ireland:
- 663,411 people have received their first dose
- 272,676 people have received their second dose
The COVID-19 Dashboard provides up-to-date information on the key indicators of COVID-19 in the community including daily data on Ireland’s COVID-19 Vaccination Programme.
New Cases in Laois
- April 6 – 6
- April 5 – 12
- April 4 – 7
- April 3 – 12
- April 2 – 20
- April 1 – 27
- March 31 – 16
- March 30 – 14
- March 29 – 7
- March 28 – 16
- March 27 – 19
- March 26 – 17
- March 25 – 15
- March 24 – 6
- March 23 – 18
14-day case rate in Laois per 100,000 population
- April 6 – 232.6
- April 5 – 244.4
- April 2/3/4 – Not Provided
- April 1 – 222
- March 31 – 210.2
- March 30 – 197.2
- March 29 – 187.7
- March 28 – 180.6
- March 27 – 162.9
- March 26 – 145.2
- March 25 – 129.9
- March 24 – 116.9
- March 23 – 119.2
New cases in Laois during past 14 days
- April 6 – 197
- April 5 – 207
- April 2/3/4 – Not Provided
- April 1 – 188
- March 31 – 178
- March 30 – 167
- March 29 – 159
- March 28 – 153
- March 27 – 138
- March 26 – 123
- March 25 – 110
- March 24 – 99
- March 23 – 101
EMA say blood clots should be listed as rare AstraZeneca side effect
Europe’s drug regulator has found a possible link between the Oxford/AstraZeneca’s Covid-19 vaccine and rare blood clotting issues in adults who had received the shot and said it had taken into consideration all currently available evidence.
The European Medicines Agency has said the “benefit-risk remains positive” for the Oxford/AstraZeneca Covid-19 vaccine.
The EMA said blood clots should be listed as a “very rare” side effect of the AstraZeneca coronavirus vaccine but that the jab’s benefits continue to outweigh the risks.
“EMA’s safety committee has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects” of the shot, the Amsterdam-based EU drug regulator said in a statement.
“One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin,” the EMA said.
SEE ALSO – Laois man elected new president of Macra na Feirme
